Inventor · Dobbs Ferry, NY, US

Min Ding

40Patents
8h-index
71Co-inventors
78Inventor score

Filing activity: Jan 15, 1999 → Feb 1, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7153848B2 Inhibitors of HCV replication Chemistry; Metallurgy 62 Expired
US7348425B2 Inhibitors of HCV replication Chemistry; Metallurgy 41 Active
US7399758B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Human Necessities 13 Active
US9850225B2 Compounds useful as immunomodulators Emerging Cross-Sectional Technologies 11 Active
US7452876B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Human Necessities 11 Active
US7456166B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Human Necessities 11 Active
US7521442B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Human Necessities 9 Active
US7521441B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Human Necessities 9 Active
US7538102B2 Compounds for the treatment of Hepatitis C Chemistry; Metallurgy 8 Active
US7485633B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Human Necessities 8 Active
US6034113A Derivatives of 1,3,4-oxadiazolone Human Necessities 7 Expired
US7521443B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Chemistry; Metallurgy 6 Active
US7541353B2 Compounds for the treatment of hepatitis C Human Necessities 5 Active
US7541351B2 Compounds for the treatment of hepatitis C Human Necessities 5 Active
US7547690B2 Compounds for the treatment of Hepatitis C Chemistry; Metallurgy 4 Active
US9295687B1 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 3 Active
US8383094B2 Hepatitis C virus inhibitors Chemistry; Metallurgy 3 Active
US8133884B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 2 Active
US9439921B2 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 2 Active
US5948802A Benzoate derivatives of diaryl 1,3,4-oxadiazolone Human Necessities 2 Expired
US10669272B2 Substituted naphthyridinone compounds useful as T cell activators Human Necessities 2 Active
US10039780B2 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 1 Active
US9738642B2 Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders Chemistry; Metallurgy 1 Active
US9700575B2 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 1 Active
US11058672B2 Pharmaceutical compositions and methods for producing low impurity concentrations of the same Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.